Clinical Trials Browser

Phase 3 × tremelimumab × 30 days × Clear all

NCT03164616 2026-03-13

POSEIDON

Phase 3 Active not recruiting

1,186 enrolled 26 charts 1 FDA

Non Small Cell Lung Cancer NSCLC

NCT02453282 2026-03-02

MYSTIC

Phase 3 Active not recruiting

1,118 enrolled 40 charts

Carcinoma, Non-Small-Cell Lung

NCT05883644 2026-02-18

SIERRA

Phase 3 Active not recruiting

Gastrointestinal

Liver Neoplasms